About the Authors

Xavier M. Teitsma

Contributed equally to this work with: Xavier M. Teitsma, Jenny Devenport, Johannes W. G. Jacobs, Attila Pethö-Schramm, Michelle E. A. Borm, Petra Budde, Johannes W. J. Bijlsma, Floris P. J. G. Lafeber

Roles Conceptualization, Formal analysis, Writing – original draft, Writing – review & editing

xavierteitsma@gmail.com

Affiliations Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands, Department of Rheumatology & Clinical Immunology, Utrecht University, Utrecht, Netherlands

Jenny Devenport

Contributed equally to this work with: Xavier M. Teitsma, Jenny Devenport, Johannes W. G. Jacobs, Attila Pethö-Schramm, Michelle E. A. Borm, Petra Budde, Johannes W. J. Bijlsma, Floris P. J. G. Lafeber

Roles Conceptualization, Formal analysis, Writing – original draft, Writing – review & editing

Affiliation Pharmaceuticals Division, F. Hoffmann-La Roche, Basel, Switzerland

Johannes W. G. Jacobs

Contributed equally to this work with: Xavier M. Teitsma, Jenny Devenport, Johannes W. G. Jacobs, Attila Pethö-Schramm, Michelle E. A. Borm, Petra Budde, Johannes W. J. Bijlsma, Floris P. J. G. Lafeber

Roles Conceptualization, Formal analysis, Writing – original draft, Writing – review & editing

Affiliations Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands, Department of Rheumatology & Clinical Immunology, Utrecht University, Utrecht, Netherlands

Attila Pethö-Schramm

Contributed equally to this work with: Xavier M. Teitsma, Jenny Devenport, Johannes W. G. Jacobs, Attila Pethö-Schramm, Michelle E. A. Borm, Petra Budde, Johannes W. J. Bijlsma, Floris P. J. G. Lafeber

Roles Conceptualization, Formal analysis, Writing – original draft, Writing – review & editing

Affiliation Pharmaceuticals Division, F. Hoffmann-La Roche, Basel, Switzerland

Michelle E. A. Borm

Contributed equally to this work with: Xavier M. Teitsma, Jenny Devenport, Johannes W. G. Jacobs, Attila Pethö-Schramm, Michelle E. A. Borm, Petra Budde, Johannes W. J. Bijlsma, Floris P. J. G. Lafeber

Roles Conceptualization, Formal analysis, Writing – original draft, Writing – review & editing

Affiliation Roche Nederland BV, Woerden, Netherlands

Petra Budde

Contributed equally to this work with: Xavier M. Teitsma, Jenny Devenport, Johannes W. G. Jacobs, Attila Pethö-Schramm, Michelle E. A. Borm, Petra Budde, Johannes W. J. Bijlsma, Floris P. J. G. Lafeber

Roles Data curation, Formal analysis, Writing – original draft, Writing – review & editing

Affiliation Department of Medical Research, Oncimmune Germany GmbH, Dortmund, Germany

Johannes W. J. Bijlsma

Contributed equally to this work with: Xavier M. Teitsma, Jenny Devenport, Johannes W. G. Jacobs, Attila Pethö-Schramm, Michelle E. A. Borm, Petra Budde, Johannes W. J. Bijlsma, Floris P. J. G. Lafeber

Roles Formal analysis, Writing – original draft, Writing – review & editing

Affiliations Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands, Department of Rheumatology & Clinical Immunology, Utrecht University, Utrecht, Netherlands

Floris P. J. G. Lafeber

Contributed equally to this work with: Xavier M. Teitsma, Jenny Devenport, Johannes W. G. Jacobs, Attila Pethö-Schramm, Michelle E. A. Borm, Petra Budde, Johannes W. J. Bijlsma, Floris P. J. G. Lafeber

Roles Conceptualization, Formal analysis, Writing – original draft, Writing – review & editing

Affiliations Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands, Department of Rheumatology & Clinical Immunology, Utrecht University, Utrecht, Netherlands

Competing Interests

The authors who enrolled patients (JWJB and JWGJ) received reimbursement for the included patients from Roche Nederland BV. JWJB reports grants and consulting fees from Roche, SUN, and Lilly. JD and AP-S hold stock/stock options in and are employees of F Hoffmann-La Roche. MEAB is an employee of Roche Nederland BV. PB is an employee of Oncimmune Germany GmbH and received reimbursement from Oncimmune Germany GmbH for performing autoantibody measurements. FPJGL reports grants from Roche. XMT is an employee of F Hoffmann-La Roche. These competing interests do not alter our adherence to PLOS ONE policies on sharing data and materials.